AI assistant
C4 Therapeutics, Inc. — Director's Dealing 2021
Oct 5, 2021
33861_dirs_2021-10-05_ce48c618-5520-4d54-a14e-7452769e37c6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: C4 Therapeutics, Inc. (CCCC)
CIK: 0001662579
Period of Report: 2021-10-04
Reporting Person: COHEN ALAIN J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-04 | Common Stock | A | 222 | $44.99 | Acquired | 222 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1804324 | Indirect |
Footnotes
F1: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
F2: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 4, 2021.
F3: This amount has been adjusted to reflect 517 shares previously transferred from the Reporting Person to the Alain J. Cohen Revocable Trust.
F4: Shares held by the Reporting Person as trustee of the Alain J. Cohen Revocable Trust.